$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(I) - 서론, 임상양상 및 공존질환 -
The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (I) - Clinical Presentation and Comorbidity - 원문보기

소아청소년정신의학 = Journal of the Korean Academy of Child and Adolescent Psychiatry, v.28 no.2, 2017년, pp.46 - 57  

김은진 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실) ,  김윤신 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실) ,  서완석 (영남대학교 의과대학 정신건강의학교실) ,  이소희 (국립중앙의료원 정신건강의학과) ,  박은진 (인제대학교 의과대학 일산백병원 정신건강의학교실) ,  배승민 (가천대학교 의과대학 길병원 정신건강의학교실) ,  신동원 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실)

Abstract AI-Helper 아이콘AI-Helper

Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder that can affect individuals across their lifespan. It is characterized by the core symptoms of inattention, impulsivity and hyperactivity. ADHD develops as a result of the complex interplay between genetic and environme...

주제어

질의응답

핵심어 질문 논문에서 추출한 답변
실행기능이란 무엇인가 실행기능은 주로 전전두엽(prefrontal cortex)에 의해 지원되는 일련의 인지적 통제 과정으로, 전전두엽은 하위 수준의 프로세스인 지각(perception), 운동 반응(motor response)을 조절하여 목표를 향한 자기 조절(self-regulation) 및 자기 주도적 행동(self-directed behavior)을 하게 하고, 습관에서 벗어나게 하며, 의사결정을 내리고 위험을 평가하고 미래를 위한 계획을 세우며 행동의 우선순위를 정하고 새로운 상황에 대처하도록 한다.29) 실행기능은 주의력(attention), 추론(reasoning), 계획(planning), 억제(inhibition), 주의전환(set-shifting), 간섭 조절(interference control), 작업 기억(working memory)으로 구성된다.
실행기능은 무엇으로 구성되는가 실행기능은 주로 전전두엽(prefrontal cortex)에 의해 지원되는 일련의 인지적 통제 과정으로, 전전두엽은 하위 수준의 프로세스인 지각(perception), 운동 반응(motor response)을 조절하여 목표를 향한 자기 조절(self-regulation) 및 자기 주도적 행동(self-directed behavior)을 하게 하고, 습관에서 벗어나게 하며, 의사결정을 내리고 위험을 평가하고 미래를 위한 계획을 세우며 행동의 우선순위를 정하고 새로운 상황에 대처하도록 한다.29) 실행기능은 주의력(attention), 추론(reasoning), 계획(planning), 억제(inhibition), 주의전환(set-shifting), 간섭 조절(interference control), 작업 기억(working memory)으로 구성된다.30) ADHD에서 실행기능의 결함은 이미 많은 연구를 통해 반복적으로 입증되었으며,31) ADHD의 기능 장애 및 증상 이 실행기능의 결함에서 발생된다고 보고되었다.
ADHD는 실행기능 중 어떤 영역에서 중대한 장애가 있는가 30) ADHD에서 실행기능의 결함은 이미 많은 연구를 통해 반복적으로 입증되었으며,31) ADHD의 기능 장애 및 증상 이 실행기능의 결함에서 발생된다고 보고되었다.32) 특히 작업 기억(working memory), 반응 억제(response inhibition), 경계(vigilance), 계획하기(planning) 등의 실행기능 영역에서 중 대한 장애가 있는 것으로 관찰되었다.32) 또한 Miller 등33)은 ADHD 환자에서 실행기능의 장애는 오랜 기간 동안 안정적으로 지속된다고 보고하였다.
질의응답 정보가 도움이 되었나요?

참고문헌 (149)

  1. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 2014;43:434-442. 

  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5(R)). 5th ed. Washington, DC: American Psychiatric Association;2013. 

  3. Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, et al. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol 2012;121:991-1010. 

  4. Egger HL, Kondo D, Angold A. The epidemiology and diagnostic issues in preschool attention-deficit/hyperactivity disorder: a review. Infants Young Child 2006;19:109-122. 

  5. Kim JY, Ahn DH, Shin YJ. An epidemiological study of attentiondeficits hyperactivity disorder and learning disabilities in a rural area. J Korean Neuropsychiatr Assoc 1999;38:784-793. 

  6. Kim JW, Park KH, Choi MJ. Screening for attention deficit/hyperactivity disorder in community mental health services for children. J Korean Neuropsychiatr Assoc 2004;43:200-208. 

  7. Yang SJ, Cheong S, Hong SD. Prevalence and correlates of attention deficit hyperactivity disorder: school-based mental health services in Seoul. J Korean Neuropsychiatr Assoc 2006;45:69-76. 

  8. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization world mental health survey initiative. Biol Psychiatry 2009;65:46-54. 

  9. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012;9:490-499. 

  10. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723. 

  11. Park S, Cho MJ, Chang SM, Jeon HJ, Cho SJ, Kim BS, et al. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study. Psychiatry Res 2011;186:378-383. 

  12. Kwak YS, Jung YE, Kim MD. Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students. Neuropsychiatr Dis Treat 2015;11:797-802. 

  13. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45:1284-1293. 

  14. Riddle MA, Yershova K, Lazzaretto D, Paykina N, Yenokyan G, Greenhill L, et al. The preschool attention-deficit/hyperactivity disorder treatment study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry 2013;52:264-278.e2. 

  15. Epstein JN, Langberg JM, Lichtenstein PK, Kolb R, Simon JO. The myADHDportal.com improvement program: an innovative quality improvement intervention for improving the quality of ADHD care among community-based pediatricians. Clin Pract Pediatr Psychol 2013;1:55-67. 

  16. Goodman DW, Surman CB, Scherer PB, Salinas GD, Brown JJ. Assessment of physician practices in adult attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord 2012;14:PCC.11m01312. 

  17. Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 2012;69:1295-1303. 

  18. McCann BS, Roy-Byrne P. Screening and diagnostic utility of self-report attention deficit hyperactivity disorder scales in adults. Compr Psychiatry 2004;45:175-183. 

  19. Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27:187-201. 

  20. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000;157:816-818. 

  21. Kessler RC, Green JG, Adler LA, Barkley RA, Chatterji S, Faraone SV, et al. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the adult ADHD clinical diagnostic scale. Arch Gen Psychiatry 2010;67:1168-1178. 

  22. Asherson P, Buitelaar J, Faraone SV, Rohde LA. Adult attention-deficit hyperactivity disorder: key conceptual issues. Lancet Psychiatry 2016;3:568-578. 

  23. Biederman J, Petty CR, Fried R, Kaiser R, Dolan CR, Schoenfeld S, et al. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry 2008;69:1217-1222. 

  24. Bouchard G, Saint-Aubin J. Attention deficits and divorce. Can J Psychiatry 2014;59:480-486. 

  25. Mannuzza S, Klein RG, Moulton JL 3rd. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res 2008;160:237-246. 

  26. de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO world mental health survey initiative. Occup Environ Med 2008;65:835-842. 

  27. Caye A, Spadini AV, Karam RG, Grevet EH, Rovaris DL, Bau CH, et al. Predictors of persistence of ADHD into adulthood: a systematic review of the literature and meta-analysis. Eur Child Adolesc Psychiatry 2016;25:1151-1159. 

  28. Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M, et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry 2015;172:967-977. 

  29. Miyake A, Friedman NP. The nature and organization of individual differences in executive functions: four general conclusions. Curr Dir Psychol Sci 2012;21:8-14. 

  30. Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry 1996;37:51-87. 

  31. Biederman J, Monuteaux MC, Doyle AE, Seidman LJ, Wilens TE, Ferrero F, et al. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol 2004;72:757-766. 

  32. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 2005;57: 1336-1346. 

  33. Miller M, Ho J, Hinshaw SP. Executive functions in girls with ADHD followed prospectively into young adulthood. Neuropsychology 2012;26:278-287. 

  34. Baddeley A. Working memory: looking back and looking forward. Nat Rev Neurosci 2003;4:829-839. 

  35. Alderson RM, Hudec KL, Patros CH, Kasper LJ. Working memory deficits in adults with attention-deficit/hyperactivity disorder (ADHD): an examination of central executive and storage/rehearsal processes. J Abnorm Psychol 2013;122:532-541. 

  36. Alderson RM, Kasper LJ, Hudec KL, Patros CH. Attention-deficit/hyperactivity disorder (ADHD) and working memory in adults: a meta-analytic review. Neuropsychology 2013;27:287-302. 

  37. Sagvolden T, Aase H, Zeiner P, Berger D. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav Brain Res 1998;94:61-71. 

  38. Luman M, Oosterlaan J, Sergeant JA. The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. Clin Psychol Rev 2005;25:183-213. 

  39. Crosbie J, Arnold P, Paterson A, Swanson J, Dupuis A, Li X, et al. Response inhibition and ADHD traits: correlates and heritability in a community sample. J Abnorm Child Psychol 2013;41:497-507. 

  40. Boonstra AM, Oosterlaan J, Sergeant JA, Buitelaar JK. Executive functioning in adult ADHD: a meta-analytic review. Psychol Med 2005;35:1097-1108. 

  41. Epstein JN, Hwang ME, Antonini T, Langberg JM, Altaye M, Arnold LE. Examining predictors of reaction times in children with ADHD and normal controls. J Int Neuropsychol Soc 2010;16:138-147. 

  42. Wahlstedt C. Neuropsychological deficits in relation to symptoms of ADHD: independent contributions and interactions. Child Neuropsychol 2009;15:262-279. 

  43. Hervey AS, Epstein JN, Curry JF, Tonev S, Eugene Arnold L, Keith Conners C, et al. Reaction time distribution analysis of neuropsychological performance in an ADHD sample. Child Neuropsychol 2006;12:125-140. 

  44. Klotz JM, Johnson MD, Wu SW, Isaacs KM, Gilbert DL. Relationship between reaction time variability and motor skill development in ADHD. Child Neuropsychol 2012;18:576-585. 

  45. Musser ED, Galloway-Long HS, Frick PJ, Nigg JT. Emotion regulation and heterogeneity in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2013;52:163-171.e2. 

  46. Graziano PA, McNamara JP, Geffken GR, Reid AM. Differentiating co-occurring behavior problems in children with ADHD: patterns of emotional reactivity and executive functioning. J Atten Disord 2013;17:249-260. 

  47. Brotman MA, Rich BA, Guyer AE, Lunsford JR, Horsey SE, Reising MM, et al. Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. Am J Psychiatry 2010;167:61-69. 

  48. Barkley RA, Murphy KR, Fischer M. ADHD in adults what the science says. New York: Guilford;2008. 

  49. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009;194:204-211. 

  50. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-289. 

  51. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006;36:159-165. 

  52. Bedard AC, Trampush JW, Newcorn JH, Halperin JM. Perceptual and motor inhibition in adolescents/young adults with childhood-diagnosed ADHD. Neuropsychology 2010;24:424-434. 

  53. McAuley T, Crosbie J, Charach A, Schachar R. The persistence of cognitive deficits in remitted and unremitted ADHD: a case for the state-independence of response inhibition. J Child Psychol Psychiatry 2014;55:292-300. 

  54. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996;53: 437-446. 

  55. Barkley RA, Fischer M. The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. J Am Acad Child Adolesc Psychiatry 2010;49:503-513. 

  56. Safren SA, Sprich SE, Cooper-Vince C, Knouse LE, Lerner JA. Life impairments in adults with medication-treated ADHD. J Atten Disord 2010;13:524-531. 

  57. Prince JB. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr Clin N Am 2006;15:13-50. 

  58. Knouse LE, Cooper-Vince C, Sprich S, Safren SA. Recent developments in the psychosocial treatment of adult ADHD. Expert Rev Neurother 2008;8:1537-1548. 

  59. Zylowska L, Ackerman DL, Yang MH, Futrell JL, Horton NL, Hale TS, et al. Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord 2008;11:737-746. 

  60. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1313-1323. 

  61. Akutagava-Martins GC, Salatino-Oliveira A, Kieling CC, Rohde LA, Hutz MH. Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. Expert Rev Neurother 2013;13:435-445. 

  62. Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 2010;33:159-180. 

  63. Kan KJ, Dolan CV, Nivard MG, Middeldorp CM, van Beijsterveldt CE, Willemsen G, et al. Genetic and environmental stability in attention problems across the lifespan: evidence from the Netherlands twin register. J Am Acad Child Adolesc Psychiatry 2013;52:12-25. 

  64. Larsson H, Asherson P, Chang Z, Ljung T, Friedrichs B, Larsson JO, et al. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins. Psychol Med 2013;43:197-207. 

  65. Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM, et al. Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS One 2010;5:e10621. 

  66. Brikell I, Kuja-Halkola R, Larsson H. Heritability of attentiondeficit hyperactivity disorder in adults. Am J Med Genet B Neuropsychiatr Genet 2015 Jun 30 [Epub ahead of print]. http://dx.doi.org/10.1002/ajmg.b.32335. 

  67. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009;126:51-90. 

  68. Bruxel EM, Akutagava-Martins GC, Salatino-Oliveira A, Contini V, Kieling C, Hutz MH, et al. ADHD pharmacogenetics across the life cycle: New findings and perspectives. Am J Med Genet B Neuropsychiatr Genet 2014;165B:263-282. 

  69. Scassellati C, Bonvicini C, Faraone SV, Gennarelli M. Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry 2012;51:1003-1019.e20. 

  70. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010;376:1401-1408. 

  71. Stergiakouli E, Hamshere M, Holmans P, Langley K, Zaharieva I; deCODE Genetics, et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012;169:186-194. 

  72. Gatt JM, Burton KL, Williams LM, Schofield PR. Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res 2015;60:1-13. 

  73. Antshel KM, Fremont W, Roizen NJ, Shprintzen R, Higgins AM, Dhamoon A, et al. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2006;45:596-603. 

  74. Langley K, Rice F, van den Bree MB, Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr 2005;57:359-371. 

  75. Thapar A, Cooper M, Eyre O, Langley K. What have we learnt about the causes of ADHD? J Child Psychol Psychiatry 2013;54:3-16. 

  76. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 2002;288:728-737. 

  77. Nigg JT. ADHD, lead exposure and prevention: how much lead or how much evidence is needed? Expert Rev Neurother 2008;8:519-521. 

  78. Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG. Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics 2010;125:e1270-e1277. 

  79. Eubig PA, Aguiar A, Schantz SL. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect 2010;118:1654-1667. 

  80. Nigg JT, Lewis K, Edinger T, Falk M. Meta-analysis of attentiondeficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry 2012;51:86-97.e8. 

  81. Pheula GF, Rohde LA, Schmitz M. Are family variables associated with ADHD, inattentive type? A case-control study in schools. Eur Child Adolesc Psychiatry 2011;20:137-145. 

  82. Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord 2002;5:189-202. 

  83. Larson K, Russ SA, Kahn RS, Halfon N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 2011;127:462-470. 

  84. Pliszka SR, Carlson CL, Swanson JM. ADHD with comorbid disorders: clinical assessment and management. New York: Guilford Press;1999. 

  85. Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001;40:147-158. 

  86. Spencer T, Biederman J, Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am 1999;46:915-927, vii. 

  87. Hong KE, Kim JH, Shin MS, Ahn DH. Diagnostic classification and assessment of psychiatrically referred children with inattention or hyperactivity. Korean J Child Adolesc Psychiatry 1996;7:190-202. 

  88. Byun H, Yang J, Lee M, Jang W, Yang JW, Kim JH, et al. Psychiatric comorbidity in Korean children and adolescents with attention-deficit hyperactivity disorder: psychopathology according to subtype. Yonsei Med J 2006;47:113-121. 

  89. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime version-Korean version (K-SADS-PL-K). Yonsei Med J 2004;45:81-89. 

  90. Barkley RA. Attention-deficit hyperactivity disorder: a clinical workbook. 2nd ed. New York: Guilford Press;1998. 

  91. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 1996;37:393-401. 

  92. Vitiello B, Lazzaretto D, Yershova K, Abikoff H, Paykina N, Mc-Cracken JT, et al. Pharmacotherapy of the preschool ADHD treatment study (PATS) children growing up. J Am Acad Child Adolesc Psychiatry 2015;54:550-556. 

  93. Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A, et al. Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the preschoolers with attention-deficit/hyperactivity disorder treatment Study (PATS). J Child Adolesc Psychopharmacol 2007;17:547-562. 

  94. Souza I, Pinheiro MA, Mattos P. Anxiety disorders in an attention-deficit/hyperactivity disorder clinical sample. Arq Neuropsiquiatr 2005;63:407-409. 

  95. Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. J Pediatr Psychol 2007;32:643-654. 

  96. Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry 2012; 53:1036-1043. 

  97. Dopfner M, Breuer D, Wille N, Erhart M, Ravens-Sieberer U; BELLA study group. How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study. Eur Child Adolesc Psychiatry 2008;17 Suppl 1:59-70. 

  98. Instanes JT, Klungsoyr K, Halmoy A, Fasmer OB, Haavik J. Adult ADHD and comorbid somatic disease: a systematic literature review. J Atten Disord 2016 Sep 22 [Epub ahead of print]. http://dx.doi.org/10.1177/1087054716669589. 

  99. Erskine HE, Norman RE, Ferrari AJ, Chan GCK, Copeland WE, Whiteford HA, et al. Long-term outcomes of attention-deficit/hyperactivity disorder and conduct disorder: a systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2016;55:841-850. 

  100. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005;57:1215-1220. 

  101. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry 1996;35:1213-1226. 

  102. Acosta MT, Castellanos F, Bolton KL, Balog JZ, Eagen P, Nee L, et al. Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions. J Am Acad Child Adolesc Psychiatry 2008;47:797-807. 

  103. Connor DF, Steeber J, McBurnett K. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr 2010;31:427-440. 

  104. Kang JW, Park EJ, Kim SC, Shin YJ, Shin YM, Jung J, et al. Pharmacotherapy of comorbid disruptive behavioral disorders in children and adolescents with ADHD. J Korean Acad Child Adolesc Psychiatry 2012;23(Suppl):S55-S65. 

  105. Park JH, Kim BN, Kim JW, Kim JH, Son JW, Shin D, et al. A preliminary study on the development of Korean medication algorithm for attention-deficit hyperactivity disorder. J Korean Acad Child Adolesc Psychiatry 2011;22:25-37. 

  106. Pliszka SR. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management. Paediatr Drugs 2003;5:741-750. 

  107. Ter-Stepanian M, Grizenko N, Zappitelli M, Joober R. Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. Can J Psychiatry 2010;55:305-312. 

  108. Elia J, Ambrosini P, Berrettini W. ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents. Child Adolesc Psychiatry Ment Health 2008;2:15. 

  109. Ostrander R, Crystal DS, August G. Attention deficit-hyperactivity disorder, depression, and self- and other-assessments of social competence: a developmental study. J Abnorm Child Psychol 2006;34:773-787. 

  110. Rohde LA, Faraone SV. Attention deficit hyperactivity disorder. Preface. Child Adolesc Psychiatr Clin N Am 2008;17:xvii-xix. 

  111. Gau SS, Ni HC, Shang CY, Soong WT, Wu YY, Lin LY, et al. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder. Aust N Z J Psychiatry 2010;44:135-143. 

  112. Freitag CM, Rohde LA, Lempp T, Romanos M. Phenotypic and measurement influences on heritability estimates in childhood ADHD. Eur Child Adolesc Psychiatry 2010;19:311-323. 

  113. Rosler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006;256 Suppl 1:i3-i11. 

  114. Biederman J, Ball SW, Monuteaux MC, Mick E, Spencer TJ, McCreary M, et al. New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry 2008;47:426-434. 

  115. Bowen R, Chavira DA, Bailey K, Stein MT, Stein MB. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Res 2008; 157:201-209. 

  116. Park EJ, Bhang SY, Seo CS, Lee YS, Hwang JW, Kwack YS. Treatment of comorbid anxiety and mood disorder in ADHD. J Korean Acad Child Adolesc Psychiatry 2012;23(Suppl):S46-S54. 

  117. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 2004;45:195-211. 

  118. Taylor E, Sandberg S, Thorley G. The epidemiology of childhood hyperactivity. Oxford: Oxford University Press;1991. 

  119. Serra-Pinheiro MA, Coutinho ES, Souza IS, Pinna C, Fortes D, Araujo C, et al. Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation. J Atten Disord 2013;17:459-469. 

  120. Spencer T, Biederman M, Coffey B, Geller D, Wilens T, Faraone S. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:842-847. 

  121. Ahn DH, Kang HY, Kim BN, Kim JH, Shin DW, Yang SJ, et al. The Korean practice parameter for the treatment of attention-deficit hyperactivity disorder(I)-introduction, clinical features and course. J Korean Acad Child Adolesc Psychiatry 2007;18:3-9. 

  122. Oluwabusi OO, Parke S, Ambrosini PJ. Tourette syndrome associated with attention deficit hyperactivity disorder: the impact of tics and psychopharmacological treatment options. World J Clin Pediatr 2016;5:128-135. 

  123. Rizzo R, Gulisano M, Cali PV, Curatolo P. Tourette syndrome and comorbid ADHD: current pharmacological treatment options. Eur J Paediatr Neurol 2013;17:421-428. 

  124. Spencer TJ, Biederman J, Faraone S, Mick E, Coffey B, Geller D, et al. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry 2001;158:611-617. 

  125. Peterson BS, Pine DS, Cohen P, Brook JS. Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry 2001;40:685-695. 

  126. Biederman J, Klein RG, Pine DS, Klein DF. Resolved: mania is mistaken for ADHD in prepubertal children. J Am Acad Child Adolesc Psychiatry 1998;37:1091-1096; discussion 1096-1099. 

  127. Biederman J, Petty CR, Byrne D, Wong P, Wozniak J, Faraone SV. Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study. J Affect Disord 2009;119:16-21. 

  128. Hassan A, Agha SS, Langley K, Thapar A. Prevalence of bipolar disorder in children and adolescents with attention-deficit hyper-activity disorder. Br J Psychiatry 2011;198:195-198. 

  129. McGough JJ, Loo SK, McCracken JT, Dang J, Clark S, Nelson SF, et al. CBCL pediatric bipolar disorder profile and ADHD: comorbidity and quantitative trait loci analysis. J Am Acad Child Adolesc Psychiatry 2008;47:1151-1157. 

  130. Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N, et al. Attention-deficit hyperactivity disorder--bipolar comorbidity in children and adolescents. Bipolar Disord 2006;8:373-381. 

  131. Geller B, Zimerman B, Williams M, DelBello MP, Bolhofner K, Craney JL, et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attentiondeficit hyperactive and normal controls. J Child Adolesc Psychopharmacol 2002;12:11-25. 

  132. Donfrancesco R, Miano S, Martines F, Ferrante L, Melegari MG, Masi G. Bipolar disorder co-morbidity in children with attention deficit hyperactivity disorder. Psychiatry Res 2011;186:333-337. 

  133. Lus G, Mukaddes NM. Co-morbidity of bipolar disorder in children and adolescents with attention deficit/hyperactivity disorder (ADHD) in an outpatient Turkish sample. World J Biol Psychiatry 2009;10(4 Pt 2):488-494. 

  134. Ryden E, Thase ME, Straht D, Aberg-Wistedt A, Bejerot S, Landen M. A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand 2009;120:239-246. 

  135. Biederman J, Mick E, Faraone SV, Van Patten S, Burback M, Wozniak J. A prospective follow-up study of pediatric bipolar disorder in boys with attention-deficit/hyperactivity disorder. J Affect Disord 2004;82 Suppl 1:S17-S23. 

  136. Walshaw PD, Alloy LB, Sabb FW. Executive function in pediatric bipolar disorder and attention-deficit hyperactivity disorder: in search of distinct phenotypic profiles. Neuropsychol Rev 2010;20:103-120. 

  137. Lynskey MT, Hall W. Attention deficit hyperactivity disorder and substance use disorders: is there a causal link? Addiction 2001;96:815-822. 

  138. Huss M, Lehmkuhl U. Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. J Atten Disord 2002;6 Suppl 1:S65-S71. 

  139. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:37-44. 

  140. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997;36:21-29. 

  141. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011;31:328-341. 

  142. Bizzarri JV, Rucci P, Sbrana A, Gonnelli C, Massei GJ, Ravani L, et al. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders. Addict Behav 2007;32:384-391. 

  143. Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 2003;112:497-507. 

  144. Yoo HJ, Cho SC, Ha J, Yune SK, Kim SJ, Hwang J, et al. Attention deficit hyperactivity symptoms and internet addiction. Psychiatry Clin Neurosci 2004;58:487-494. 

  145. Ko CH, Yen JY, Chen CS, Chen CC, Yen CF. Psychiatric comorbidity of internet addiction in college students: an interview study. CNS Spectr 2008;13:147-153. 

  146. Groman SM, James AS, Jentsch JD. Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder. Neurosci Biobehav Rev 2009;33:690-698. 

  147. Frodl T. Comorbidity of ADHD and substance use disorder (SUD): a neuroimaging perspective. J Atten Disord 2010;14:109-120. 

  148. Kollins SH. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord 2008;12:115-125. 

  149. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 2008;165:597-603. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로